Cargando…
Boosting care and knowledge about hereditary cancer: European Reference Network on Genetic Tumour Risk Syndromes
Approximately 27–36 million patients in Europe have one of the ~ 5.000–8.000 known rare diseases. These patients often do not receive the care they need or they have a substantial delay from diagnosis to treatment. In March 2017, twenty-four European Reference Networks (ERNs) were launched with the...
Autores principales: | Vos, Janet R., Giepmans, Lisette, Röhl, Claas, Geverink, Nicoline, Hoogerbrugge, Nicoline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449296/ https://www.ncbi.nlm.nih.gov/pubmed/30302652 http://dx.doi.org/10.1007/s10689-018-0110-6 |
Ejemplares similares
-
European Reference Networks: challenges and opportunities
por: Tumiene, Birute, et al.
Publicado: (2021) -
Response to Tomao, Panici, and Tomao
por: Vos, Janet R, et al.
Publicado: (2019) -
Cancer Surveillance Guideline for individuals with PTEN hamartoma tumour syndrome
por: Tischkowitz, Marc, et al.
Publicado: (2020) -
Universal genetic assessment for women with ovarian cancer not yet achieved: The promises of universal tumor DNA testing
por: Witjes, Vera M., et al.
Publicado: (2021) -
Candidate Gene Discovery in Hereditary Colorectal Cancer and Polyposis Syndromes–Considerations for Future Studies
por: te Paske, Iris B. A. W., et al.
Publicado: (2020)